SCHEMBL7107045

SCHEMBL7107045

COC(=O)CC(C)N1CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.46
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM1A O60341 1/20 0.38
TSHR P16473 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HTT P42858 1/20 0.37
LIPE Q05469 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9774544 0.83 MAPT (0.47) ALDH1A1KMT2ALMNAMAPTRAB9A
SCHEMBL10706719 0.83 LMNA (0.44) ALDH1A1KMT2ALMNAMAPTHPGD
SCHEMBL9774519 0.81 ALDH1A1 (0.46) ALDH1A1KMT2ALMNAMAPTNPSR1
SCHEMBL9774580 0.81 ALDH1A1 (0.46) ALDH1A1KMT2ALMNAMAPTNPSR1
SCHEMBL17821060 0.81 USP2 (0.47) ALDH1A1KMT2ALMNAMAPTHPGD
SCHEMBL13778238 0.80 TSHR (0.38) ALDH1A1KMT2AMAPTMEN1SMN1; SMN2
SCHEMBL16075561 0.79 ALDH1A1 (0.42) ALDH1A1KMT2ALMNAMAPTHPGD
SCHEMBL9583332 0.79 ALDH1A1 (0.42) ALDH1A1KMT2ALMNAMAPTHPGD
SCHEMBL500092 0.79 ALDH1A1 (0.46) GLAALDH1A1KMT2ALMNAMAPT
SCHEMBL9621841 0.79 ALDH1A1 (0.44) GLAALDH1A1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0112603-B2 APHIDICOLANE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-03-18 EP claimed
US-4803201-A Homocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-07 US claimed
EP-0112603-B1 APHIDICOLANE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-03-04 EP claimed
EP-0112603-A1 Aphidicolane derivatives, their preparation and pharmaceutical compositions comprising them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-07-04 EP claimed
EP-3625316-B1 DISPERSANTS, METHOD OF MAKING, AND USING SAME CHEVRON ORONITE CO (US) 2023-08-23 EP disclosed
CN-110621766-B Dispersant, method of manufacture and use thereof 雪佛龙奥伦耐有限责任公司 2021-12-24 CN disclosed
US-10815446-B2 Dispersants, method of making, and using same CHEVRON ORONITE COMPANY LLC (US) 2020-10-27 US disclosed
EP-3169745-B1 HYDROFLUOROETHER OLEFINS AND METHODS OF USING SAME 3M INNOVATIVE PROPERTIES CO (US) 2020-04-29 EP disclosed
CN-110621766-A Dispersant, method of manufacture and use thereof 雪佛龙奥伦耐有限责任公司 2019-12-27 CN disclosed
US-10385249-B2 Hydrofluoroether olefins and methods of using same 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-20 US disclosed
US-10208210-B2 Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body MITSUBISHI MATERIALS CORPORATION (JP) 2019-02-19 US disclosed
US-20180334635-A1 DISPERSANTS, METHOD OF MAKING, AND USING SAME CHEVRON ORONITE COMPANY LLC 2018-11-22 US disclosed
US-20030144249-A1 Use of organophosphorous compounds for producing a medicament for treating infections JOMAA PHARMAKA GMBH (DE) 2003-07-31 US disclosed
EP-0112603-B2 APHIDICOLANE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-03-18 EP disclosed
US-5039710-A Homocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-08-13 US disclosed
US-4985556-A INTERMEDIATES AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1991-01-15 US disclosed
US-4803201-A Homocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-07 US disclosed
US-4012445-A Beta-amino carbonyl catalysts for polyurethane preparation UNION CARBIDE CORPORATION (US) 1977-03-15 US disclosed
US-4011223-A POLYMERIZATION CATALYSTS, POLYURETHANES UNION CARBIDE CORPORATION (US) 1977-03-08 US disclosed
US-3954749-A MORPHOLINE DERIVATIVES OF AMIDES UNION CARBIDE CORPORATION (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144249-A1 Use of organophosphorous compounds for producing a medicament for treating infections PHPT1, PPM1D, BPNT1 GLA 3728/4885ALDH1A1 1560/4885KMT2A 3210/4885
US-10208210-B2 Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body FABP4, FFAR1, FFAR2 GLA 3426/4885ALDH1A1 3491/4885KMT2A 1177/4885
US-10385249-B2 Hydrofluoroether olefins and methods of using same SLC46A1, CYP4F2, FANCF GLA 1347/4885ALDH1A1 1393/4885KMT2A 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.